US$ 22.61
dihexa safety human studies EllieMD dihexa human studies clinical trials
Description
The active component was sequenced as a nine-residue peptide with no homology to other neuropeptides

Body Protection Compound-157 is a synthetic pentadecapeptide sequence studied in laboratory settings for its structural and regenerative properties in vitro

DCR of the two groups was 81% and 83% and the median PFS was 5.5 months and 6.8 months, respectively

Mark the date of first use on the vial

Recovery Support, Inflammation Management, performance optimization and more

If it says anything different, you need a different chart
